These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36920577)

  • 1. Individuals with type 2 diabetes have higher density of small intestinal neurotensin-expressing cells.
    Ferreira FP; Pereira SS; Costa MM; Guimarães M; Albrechtsen NJW; Holst JJ; Nora M; Monteiro MP
    Mol Cell Biochem; 2023 Dec; 478(12):2779-2787. PubMed ID: 36920577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential GIP/GLP-1 intestinal cell distribution in diabetics' yields distinctive rearrangements depending on Roux-en-Y biliopancreatic limb length.
    Palha AM; Pereira SS; Costa MM; Morais T; Maia AF; Guimarães M; Nora M; Monteiro MP
    J Cell Biochem; 2018 Sep; 119(9):7506-7514. PubMed ID: 29761876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed characterization of incretin cell distribution along the human small intestine.
    Guedes TP; Martins S; Costa M; Pereira SS; Morais T; Santos A; Nora M; Monteiro MP
    Surg Obes Relat Dis; 2015; 11(6):1323-31. PubMed ID: 26048514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity.
    Barchetta I; Cimini FA; Capoccia D; Bertoccini L; Ceccarelli V; Chiappetta C; Leonetti F; Di Cristofano C; Silecchia G; Orho-Melander M; Melander O; Cavallo MG
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29690638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Neurotensin and Its Receptors Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls.
    Gilliam-Vigh H; Jorsal T; Nielsen SW; Forman JL; Pedersen J; Poulsen SS; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2023 Aug; 108(9):2211-2216. PubMed ID: 36916883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission.
    Castagneto Gissey L; Casella Mariolo J; Mingrone G
    Peptides; 2018 Feb; 100():114-122. PubMed ID: 29412812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes remission after bariatric surgery: is it just the incretins?
    Laferrère B
    Int J Obes (Lond); 2011 Sep; 35 Suppl 3(0 3):S22-5. PubMed ID: 21912382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin Regulates Proliferation and Stem Cell Function in the Small Intestine in a Nutrient-Dependent Manner.
    Rock SA; Jiang K; Wu Y; Liu Y; Li J; Weiss HL; Wang C; Jia J; Gao T; Evers BM
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):501-516. PubMed ID: 34560309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls.
    Gilliam-Vigh H; Jorsal T; Nielsen SW; Forman JL; Pedersen J; Poulsen SS; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2023 Nov; 108(12):e1597-e1602. PubMed ID: 37335970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery.
    Mingrone G; Castagneto-Gissey L
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):518-23. PubMed ID: 20152737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal milieu and the interplay of multiple antidiabetic effects after gastric bypass surgery.
    Pal A; Rhoads DB; Tavakkoli A
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G668-G678. PubMed ID: 30896970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass?
    Chondronikola M; Harris LL; Klein S
    J Intern Med; 2016 Nov; 280(5):476-486. PubMed ID: 27739136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on neurotensin. II. Release of neurotensin.
    Fujimura M
    Nihon Geka Hokan; 1989 Sep; 58(5):414-30. PubMed ID: 2642265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?
    Bose M; Oliván B; Teixeira J; Pi-Sunyer FX; Laferrère B
    Obes Surg; 2009 Feb; 19(2):217-229. PubMed ID: 18820978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMALL INTESTINAL L CELL DENSITY IN PATIENTS WITH SEVERE OBESITY AFTER ROUX-EN-Y GASTRIC BYPASS.
    Estabile PC; Santo MA; Moura EGH; Kuga R; Caproni P; Cleva R; Mota FC; Milléo FQ; Artoni RF
    Arq Bras Cir Dig; 2022; 35():e1681. PubMed ID: 36197372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty.
    Svane MS; Øhrstrøm CC; Plamboeck A; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Martinussen C; Vilsbøll T; Hartmann B; Deacon CF; Kristiansen VB; Knop FK; Svendsen LB; Madsbad S; Holst JJ; Veedfald S
    Neurogastroenterol Motil; 2022 Jan; 34(1):e14210. PubMed ID: 34378827
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.